CapsoVision (CV) Cost of Revenue (2024 - 2025)

CapsoVision (CV) reported Cost of Revenue of $2.0 million for Q4 2025, up 14.32% on a YoY basis from $1.7 million in Q4 2024, and up 20.94% sequentially from $1.6 million in Q3 2025.

CapsoVision (CV) Cost of Revenue (2024 - 2025) Analysis & Trends

CapsoVision (CV) has 2 years of Cost of Revenue data on file, last reported at $2.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 14.32% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $6.8 million (changed N/A YoY), and the FY2025 full-year result was $6.4 million, up 18.63% from the prior year.
  • Cost of Revenue advanced to $2.0 million in Q4 2025, from $1.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.0 million in Q4 2025 to a low of $1.3 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 4.89 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.21 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 3.40 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 12.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 362.60 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 441.60 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 481.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 2.51 Bn
10 CapsoVision 163.05 Mn 152.94 Mn 1.95 Mn 1.96 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.96 Mn
Dec 31, 2025 1.96 Mn
Sep 30, 2025 1.62 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 1.50 Mn
Jun 30, 2025 1.50 Mn
Dec 31, 2024 1.72 Mn
Dec 31, 2024 1.72 Mn
Sep 30, 2024 1.31 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.25 Mn
Jun 30, 2024 1.25 Mn